Abiopharma

🔍 GEORGE W WHITNEY (Executive)

Company: SPROTT FOCUS TRUST INC. (FUND)

Report Date: 2026-06-30

Detailed Transactions and Holdings:

• Acquired 16,394 shares of Common Stock at $9.63 per share (Direct)
  Date: 2026-06-29 | Code: P | equity_swap_involved: false | shares_owned_after: 8,100,605.00 | transaction_form_type: 4
• Acquired 4,606 shares of Common Stock at $9.63 per share (Direct)
  Date: 2026-06-29 | Code: P | equity_swap_involved: false | shares_owned_after: 315,982.00 | transaction_form_type: 4 | Footnotes: F5
• Acquired 1,116 shares of Common Stock at $9.63 per share (Direct)
  Date: 2026-06-29 | Code: P | equity_swap_involved: false | shares_owned_after: 3,326,193.00 | transaction_form_type: 4
• Acquired 21,392 shares of Common Stock at $9.63 per share (Direct)
  Date: 2026-06-29 | Code: P | equity_swap_involved: false | shares_owned_after: 1,467,325.00 | transaction_form_type: 4 | Footnotes: F3
• Acquired 3,973 shares of Common Stock at $9.63 per share (Direct)
  Date: 2026-06-29 | Code: P | equity_swap_involved: false | shares_owned_after: 272,566.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,716 shares of Common Stock at $9.63 per share (Direct)
  Date: 2026-06-29 | Code: P | equity_swap_involved: false | shares_owned_after: 117,710.00 | transaction_form_type: 4 | Footnotes: F4
• Acquired 38,861 shares of Common Stock at $9.63 per share (Direct)
  Date: 2026-06-29 | Code: P | equity_swap_involved: false | shares_owned_after: 2,665,534.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Shares held by a trust established for the benefit of Mr. George's immediate family member (the "BM Trust"). Mr. George serves as trustee of the BM Trust and, in such capacity, has investment and voting discretion over shares held by the BM Trust. Mr. George may be deemed to beneficially own the shares held by the BM Trust.
• F2: Shares held by The Meredith and Whitney George Foundation (the "Foundation"). Mr. George serves as the Chairman of the Foundation and, in such capacity, has investment and voting discretion over shares held by the Foundation.
• F3: Shares held by a trust established for the benefit of Mr. George's children. As beneficiaries of the trust, Mr. George's children have a pecuniary interest in the trust. Mr. George may be deemed to beneficially own the shares held by the trust.
• F4: Shares held by a trust established for the benefit of Mr. George's spouse. Mr. George serves as trustee of the trust and, in such capacity, has investment and voting discretion over shares held by the trust. As beneficiary of the trust, Mr. George's spouse has a pecuniary interest in the trust. Mr. George may be deemed to beneficially own the shares held by the trust.
• F5: Shares held by a trust established for the benefit of Mr. George's immediate family member (the "TM Trust"). Mr. George serves as trustee of the TM Trust and, in such capacity, has investment and voting discretion over shares held by the TM Trust. Mr. George may be deemed to beneficially own the shares held by the TM Trust.
• REMARKS: Mr. George disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that Mr. George is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("1934 Act"), or for any other purpose. The purchases of shares of Sprott Focus Trust, Inc. were made pursuant to a dividend reinvestment plan that satisfies requirements of Rule 16a-11 under the 1934 Act. Rule 16a-11 exempts such transactions from Section 16 of the 1934 Act.